Envista Holdings Corporation has grown revenue 3.1% a year over three years and 6.1% a year over five, with earnings per share compounding at −30%. Revenue growth, 3-year annual rate: +3.1% (Medical Instruments & Supplies median +10%). Revenue growth, 5-year rate: +6.1%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −30%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 9, FY2017 to FY2025, as filed.

NVSTEnvista Holdings Corporation

HealthcareUSD

$27.81

$18.9552 weeks$30.26

Is it growing?

Is NVST growing?

Envista Holdings Corporation has grown revenue 3.1% a year over three years and 6.1% a year over five, with earnings per share compounding at −30%.

+3.1%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +10% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +6.1%
Revenue growth, 5-year rate · +3.1% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −30%
Earnings per share, 3-year rate · revenue +3.1% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed